Effect of Boozidaan(Pyrethrum Indicum)on Niqris Muzmin(chronic gout)
- Conditions
- Health Condition 1: M1A9- Chronic gout, unspecified
- Registration Number
- CTRI/2021/03/032150
- Lead Sponsor
- Central council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Irrespective of all genders
Patients between 18-65 years of age
Patients Fulfilling the criteria of American College of Rheumatology(ACR) for diagnosing gouty arthritis including clinical features, laboratory and radiological finding , having serum uric acid level >7mg/dl in males and Ë?6mg/dl in females17.
Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily
Patients below 18 and above 65 years of age
Pregnant and lactating mothers
Patients who fail to give consent
Patients of gout associated with any systemic disorder which interfere with patient study
Patients of gout associated with any severe arthritic condition such as rheumatoid arthritis, septic arthritis.
Patients suffering from anemia and other blood dyscrasias like leukemia, haemophilia,etc
Patients suffering from congenital gout
Any other disease other than Gout(Gouty arthritis).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in Signs and Symptoms of Chronic gout and normal Uric acid levelsTimepoint: 28 days
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safetyTimepoint: 28 days